BCDA
BioCardia, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.06
−2.75%14
Insider buys (3m)
0
Insider sells (3m)
$136.2K
Net value (3m)
+3.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 18, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 5,400 | $0.93 |
| Aug 13, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 1,900 | $0.92 |
| Jul 29, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 5,000 | $0.78 |
| Jul 20, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 500 | $0.83 |
| Jul 15, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 2,800 | $0.88 |
| Jul 15, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 1,500 | $0.86 |
| Jul 10, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 5,500 | $0.97 |
| Jul 10, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 1,000 | $0.90 |
| Jul 8, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 5,400 | $0.96 |
| Jul 7, 2026 | GILLIS EDWARD M · officer: Senior Vice President, Devices | F-InKind | 17,269 | $1.24 |
| Jul 7, 2026 | McClung David · officer: Chief Financial Officer | A-Award | 41,501 | $1.20 |
| Jul 7, 2026 | Blank Andrew Scott · director | A-Award | 8,000 | $1.20 |
| Jul 7, 2026 | Altman Peter · director, officer: President and CEO | F-InKind | 54,606 | $1.24 |
| Jul 7, 2026 | Facteau Bill · director | A-Award | 8,000 | $1.20 |
| Jul 7, 2026 | MOYES JAY M · director | A-Award | 8,000 | $1.20 |
| Jul 7, 2026 | Altman Peter · director, officer: President and CEO | A-Award | 57,688 | $1.20 |
| Jul 7, 2026 | McClung David · officer: Chief Financial Officer | F-InKind | 23,125 | $1.24 |
| Jul 7, 2026 | STERTZER SIMON H · director | A-Award | 8,000 | $1.20 |
| Jul 7, 2026 | Allen Jim L. · director | A-Award | 8,000 | $1.20 |
| Jul 7, 2026 | GILLIS EDWARD M · officer: Senior Vice President, Devices | A-Award | 29,442 | $1.20 |
| Jul 7, 2026 | Slosman Marvin · director | A-Award | 8,000 | $1.20 |
| Jul 1, 2026 | GILLIS EDWARD M · officer: Senior Vice President, Devices | A-Award | 39,521 | $1.20 |
| Jul 1, 2026 | Altman Peter · director, officer: President and CEO | A-Award | 110,625 | $1.20 |
| Jul 1, 2026 | McClung David · officer: Chief Financial Officer | A-Award | 60,483 | $1.20 |
| Jun 24, 2026 | STERTZER SIMON H · director | Purchase | 70,200 | $0.92 |
| Jun 24, 2026 | STERTZER SIMON H · director | Purchase | 39,000 | $1.00 |
| Jun 22, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 1,500 | $0.85 |
| Jun 22, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 800 | $0.96 |
| Jun 9, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 5,000 | $0.85 |
| May 21, 2026 | Altman Peter · director, officer: President and CEO | Purchase | 200 | $0.95 |
Institutional positioning
13F filings over the trailing two quarters
New 6Increased 5Reduced 4Sold out 17
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CM MANAGEMENT, LLC | Unchanged | 130,000 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 124,591 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 94,287 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 66,270 | May 8, 2026 |
| CITADEL ADVISORS LLC | Reduced | 63,384 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 38,827 | May 15, 2026 |
| PINGORA PARTNERS LLC | Increased | 35,739 | May 15, 2026 |
| BROWN ADVISORY INC | Unchanged | 35,538 | May 15, 2026 |
| XTX TOPCO LTD | Increased | 24,270 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 22,956 | Sep 2, 2026 |
| VIRTU FINANCIAL LLC | New Position | 20,355 | May 14, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | Unchanged | 18,283 | Apr 27, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 14,780 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | New Position | 13,900 | May 14, 2026 |
| MORGAN STANLEY | Reduced | 3,105 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 18, 2026